nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—Hepatocellular carcinoma—Entecavir—hepatitis B	0.0631	0.0631	CcSEcCtD
Acamprosate—Hepatic cirrhosis—Entecavir—hepatitis B	0.0601	0.0601	CcSEcCtD
Acamprosate—Hepatic cancer—Entecavir—hepatitis B	0.0574	0.0574	CcSEcCtD
Acamprosate—Ascites—Entecavir—hepatitis B	0.0254	0.0254	CcSEcCtD
Acamprosate—Multiple fractures—Adefovir Dipivoxil—hepatitis B	0.0194	0.0194	CcSEcCtD
Acamprosate—Fracture—Adefovir Dipivoxil—hepatitis B	0.0194	0.0194	CcSEcCtD
Acamprosate—Myopathy—Adefovir Dipivoxil—hepatitis B	0.016	0.016	CcSEcCtD
Acamprosate—Myopathy—Telbivudine—hepatitis B	0.0135	0.0135	CcSEcCtD
Acamprosate—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0123	0.0123	CcSEcCtD
Acamprosate—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0118	0.0118	CcSEcCtD
Acamprosate—Cardiomyopathy—Lamivudine—hepatitis B	0.0104	0.0104	CcSEcCtD
Acamprosate—Neck pain—Telbivudine—hepatitis B	0.00959	0.00959	CcSEcCtD
Acamprosate—Suicide attempt—Lamivudine—hepatitis B	0.00941	0.00941	CcSEcCtD
Acamprosate—Blood creatinine increased—Entecavir—hepatitis B	0.00784	0.00784	CcSEcCtD
Acamprosate—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.00765	0.00765	CcSEcCtD
Acamprosate—Myopathy—Lamivudine—hepatitis B	0.00761	0.00761	CcSEcCtD
Acamprosate—Liver function test abnormal—Adefovir Dipivoxil—hepatitis B	0.00754	0.00754	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0072	0.0072	CcSEcCtD
Acamprosate—Pancreatitis—Entecavir—hepatitis B	0.00709	0.00709	CcSEcCtD
Acamprosate—Pancreatitis—Adefovir Dipivoxil—hepatitis B	0.00692	0.00692	CcSEcCtD
Acamprosate—Amblyopia—Lamivudine—hepatitis B	0.00691	0.00691	CcSEcCtD
Acamprosate—Migraine—Telbivudine—hepatitis B	0.00677	0.00677	CcSEcCtD
Acamprosate—Hyperglycaemia—Entecavir—hepatitis B	0.00652	0.00652	CcSEcCtD
Acamprosate—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00638	0.00638	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.00619	0.00619	CcSEcCtD
Acamprosate—Haematuria—Entecavir—hepatitis B	0.00615	0.00615	CcSEcCtD
Acamprosate—Gastritis—Telbivudine—hepatitis B	0.00608	0.00608	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.00606	0.00606	CcSEcCtD
Acamprosate—Haematuria—Adefovir Dipivoxil—hepatitis B	0.006	0.006	CcSEcCtD
Acamprosate—Abdominal distension—Telbivudine—hepatitis B	0.00598	0.00598	CcSEcCtD
Acamprosate—Influenza—Telbivudine—hepatitis B	0.00594	0.00594	CcSEcCtD
Acamprosate—Rectal haemorrhage—Lamivudine—hepatitis B	0.00591	0.00591	CcSEcCtD
Acamprosate—Hepatitis—Entecavir—hepatitis B	0.00579	0.00579	CcSEcCtD
Acamprosate—Oedema peripheral—Entecavir—hepatitis B	0.0057	0.0057	CcSEcCtD
Acamprosate—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.00565	0.00565	CcSEcCtD
Acamprosate—Pharyngitis—Adefovir Dipivoxil—hepatitis B	0.00561	0.00561	CcSEcCtD
Acamprosate—Muscle twitching—Lamivudine—hepatitis B	0.00543	0.00543	CcSEcCtD
Acamprosate—Eructation—Lamivudine—hepatitis B	0.00524	0.00524	CcSEcCtD
Acamprosate—Immune system disorder—Entecavir—hepatitis B	0.00523	0.00523	CcSEcCtD
Acamprosate—Alopecia—Entecavir—hepatitis B	0.00512	0.00512	CcSEcCtD
Acamprosate—Mental disorder—Entecavir—hepatitis B	0.00507	0.00507	CcSEcCtD
Acamprosate—Malnutrition—Entecavir—hepatitis B	0.00504	0.00504	CcSEcCtD
Acamprosate—Photophobia—Lamivudine—hepatitis B	0.00501	0.00501	CcSEcCtD
Acamprosate—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00492	0.00492	CcSEcCtD
Acamprosate—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00485	0.00485	CcSEcCtD
Acamprosate—Mouth ulceration—Lamivudine—hepatitis B	0.00483	0.00483	CcSEcCtD
Acamprosate—Urine output increased—Lamivudine—hepatitis B	0.00483	0.00483	CcSEcCtD
Acamprosate—Back pain—Adefovir Dipivoxil—hepatitis B	0.00476	0.00476	CcSEcCtD
Acamprosate—Hepatitis—Telbivudine—hepatitis B	0.00476	0.00476	CcSEcCtD
Acamprosate—Hypoaesthesia—Telbivudine—hepatitis B	0.00473	0.00473	CcSEcCtD
Acamprosate—Pharyngitis—Telbivudine—hepatitis B	0.00472	0.00472	CcSEcCtD
Acamprosate—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00454	0.00454	CcSEcCtD
Acamprosate—Lymphadenopathy—Lamivudine—hepatitis B	0.00454	0.00454	CcSEcCtD
Acamprosate—Leukopenia—Entecavir—hepatitis B	0.00451	0.00451	CcSEcCtD
Acamprosate—Phlebitis—Lamivudine—hepatitis B	0.0045	0.0045	CcSEcCtD
Acamprosate—Polyuria—Lamivudine—hepatitis B	0.00441	0.00441	CcSEcCtD
Acamprosate—Gastroenteritis—Lamivudine—hepatitis B	0.00437	0.00437	CcSEcCtD
Acamprosate—Deafness—Lamivudine—hepatitis B	0.00433	0.00433	CcSEcCtD
Acamprosate—Cough—Adefovir Dipivoxil—hepatitis B	0.00429	0.00429	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00426	0.00426	CcSEcCtD
Acamprosate—Injury—Lamivudine—hepatitis B	0.00421	0.00421	CcSEcCtD
Acamprosate—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00419	0.00419	CcSEcCtD
Acamprosate—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00419	0.00419	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00416	0.00416	CcSEcCtD
Acamprosate—Malnutrition—Telbivudine—hepatitis B	0.00414	0.00414	CcSEcCtD
Acamprosate—Anaphylactic shock—Entecavir—hepatitis B	0.00411	0.00411	CcSEcCtD
Acamprosate—Infection—Entecavir—hepatitis B	0.00409	0.00409	CcSEcCtD
Acamprosate—Thirst—Lamivudine—hepatitis B	0.00407	0.00407	CcSEcCtD
Acamprosate—Dysgeusia—Telbivudine—hepatitis B	0.00405	0.00405	CcSEcCtD
Acamprosate—Back pain—Telbivudine—hepatitis B	0.004	0.004	CcSEcCtD
Acamprosate—Skin disorder—Entecavir—hepatitis B	0.004	0.004	CcSEcCtD
Acamprosate—Muscle spasms—Telbivudine—hepatitis B	0.00398	0.00398	CcSEcCtD
Acamprosate—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00393	0.00393	CcSEcCtD
Acamprosate—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.0039	0.0039	CcSEcCtD
Acamprosate—Ill-defined disorder—Telbivudine—hepatitis B	0.00384	0.00384	CcSEcCtD
Acamprosate—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00383	0.00383	CcSEcCtD
Acamprosate—Migraine—Lamivudine—hepatitis B	0.00381	0.00381	CcSEcCtD
Acamprosate—Malaise—Telbivudine—hepatitis B	0.00373	0.00373	CcSEcCtD
Acamprosate—Insomnia—Entecavir—hepatitis B	0.00372	0.00372	CcSEcCtD
Acamprosate—Somnolence—Entecavir—hepatitis B	0.00366	0.00366	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00366	0.00366	CcSEcCtD
Acamprosate—Dyspepsia—Entecavir—hepatitis B	0.00362	0.00362	CcSEcCtD
Acamprosate—Cough—Telbivudine—hepatitis B	0.00361	0.00361	CcSEcCtD
Acamprosate—Liver function test abnormal—Lamivudine—hepatitis B	0.00358	0.00358	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Entecavir—hepatitis B	0.00355	0.00355	CcSEcCtD
Acamprosate—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00353	0.00353	CcSEcCtD
Acamprosate—Arthralgia—Telbivudine—hepatitis B	0.00352	0.00352	CcSEcCtD
Acamprosate—Chest pain—Telbivudine—hepatitis B	0.00352	0.00352	CcSEcCtD
Acamprosate—Myalgia—Telbivudine—hepatitis B	0.00352	0.00352	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.0035	0.0035	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00349	0.00349	CcSEcCtD
Acamprosate—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00349	0.00349	CcSEcCtD
Acamprosate—Discomfort—Telbivudine—hepatitis B	0.00348	0.00348	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00346	0.00346	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00342	0.00342	CcSEcCtD
Acamprosate—Abdominal distension—Lamivudine—hepatitis B	0.00337	0.00337	CcSEcCtD
Acamprosate—Gastrointestinal pain—Entecavir—hepatitis B	0.00336	0.00336	CcSEcCtD
Acamprosate—Influenza—Lamivudine—hepatitis B	0.00335	0.00335	CcSEcCtD
Acamprosate—Dysphagia—Lamivudine—hepatitis B	0.00335	0.00335	CcSEcCtD
Acamprosate—Thrombocytopenia—Telbivudine—hepatitis B	0.00331	0.00331	CcSEcCtD
Acamprosate—Pancreatitis—Lamivudine—hepatitis B	0.00328	0.00328	CcSEcCtD
Acamprosate—Skin disorder—Telbivudine—hepatitis B	0.00328	0.00328	CcSEcCtD
Acamprosate—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00328	0.00328	CcSEcCtD
Acamprosate—Body temperature increased—Entecavir—hepatitis B	0.00325	0.00325	CcSEcCtD
Acamprosate—Abdominal pain—Entecavir—hepatitis B	0.00325	0.00325	CcSEcCtD
Acamprosate—Bronchitis—Lamivudine—hepatitis B	0.00322	0.00322	CcSEcCtD
Acamprosate—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00317	0.00317	CcSEcCtD
Acamprosate—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00317	0.00317	CcSEcCtD
Acamprosate—Pollakiuria—Lamivudine—hepatitis B	0.00309	0.00309	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00308	0.00308	CcSEcCtD
Acamprosate—Insomnia—Telbivudine—hepatitis B	0.00306	0.00306	CcSEcCtD
Acamprosate—Paraesthesia—Telbivudine—hepatitis B	0.00303	0.00303	CcSEcCtD
Acamprosate—Hyperglycaemia—Lamivudine—hepatitis B	0.00302	0.00302	CcSEcCtD
Acamprosate—Depression—Lamivudine—hepatitis B	0.00298	0.00298	CcSEcCtD
Acamprosate—Dyspepsia—Telbivudine—hepatitis B	0.00297	0.00297	CcSEcCtD
Acamprosate—Asthenia—Entecavir—hepatitis B	0.00295	0.00295	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00292	0.00292	CcSEcCtD
Acamprosate—Stomatitis—Lamivudine—hepatitis B	0.00291	0.00291	CcSEcCtD
Acamprosate—Pain—Telbivudine—hepatitis B	0.00289	0.00289	CcSEcCtD
Acamprosate—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00288	0.00288	CcSEcCtD
Acamprosate—Sweating—Lamivudine—hepatitis B	0.00286	0.00286	CcSEcCtD
Acamprosate—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00284	0.00284	CcSEcCtD
Acamprosate—Epistaxis—Lamivudine—hepatitis B	0.00282	0.00282	CcSEcCtD
Acamprosate—Diarrhoea—Entecavir—hepatitis B	0.00281	0.00281	CcSEcCtD
Acamprosate—Feeling abnormal—Telbivudine—hepatitis B	0.00278	0.00278	CcSEcCtD
Acamprosate—Gastrointestinal pain—Telbivudine—hepatitis B	0.00276	0.00276	CcSEcCtD
Acamprosate—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00275	0.00275	CcSEcCtD
Acamprosate—Dizziness—Entecavir—hepatitis B	0.00272	0.00272	CcSEcCtD
Acamprosate—Rhinitis—Lamivudine—hepatitis B	0.00269	0.00269	CcSEcCtD
Acamprosate—Hepatitis—Lamivudine—hepatitis B	0.00268	0.00268	CcSEcCtD
Acamprosate—Abdominal pain—Telbivudine—hepatitis B	0.00267	0.00267	CcSEcCtD
Acamprosate—Body temperature increased—Telbivudine—hepatitis B	0.00267	0.00267	CcSEcCtD
Acamprosate—Hypoaesthesia—Lamivudine—hepatitis B	0.00267	0.00267	CcSEcCtD
Acamprosate—Pharyngitis—Lamivudine—hepatitis B	0.00266	0.00266	CcSEcCtD
Acamprosate—Vomiting—Entecavir—hepatitis B	0.00262	0.00262	CcSEcCtD
Acamprosate—Rash—Entecavir—hepatitis B	0.00259	0.00259	CcSEcCtD
Acamprosate—Dermatitis—Entecavir—hepatitis B	0.00259	0.00259	CcSEcCtD
Acamprosate—Headache—Entecavir—hepatitis B	0.00258	0.00258	CcSEcCtD
Acamprosate—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00255	0.00255	CcSEcCtD
Acamprosate—Rash—Adefovir Dipivoxil—hepatitis B	0.00253	0.00253	CcSEcCtD
Acamprosate—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00253	0.00253	CcSEcCtD
Acamprosate—Headache—Adefovir Dipivoxil—hepatitis B	0.00251	0.00251	CcSEcCtD
Acamprosate—Nausea—Entecavir—hepatitis B	0.00244	0.00244	CcSEcCtD
Acamprosate—Asthenia—Telbivudine—hepatitis B	0.00242	0.00242	CcSEcCtD
Acamprosate—Immune system disorder—Lamivudine—hepatitis B	0.00242	0.00242	CcSEcCtD
Acamprosate—Chills—Lamivudine—hepatitis B	0.0024	0.0024	CcSEcCtD
Acamprosate—Pruritus—Telbivudine—hepatitis B	0.00239	0.00239	CcSEcCtD
Acamprosate—Nausea—Adefovir Dipivoxil—hepatitis B	0.00238	0.00238	CcSEcCtD
Acamprosate—Alopecia—Lamivudine—hepatitis B	0.00237	0.00237	CcSEcCtD
Acamprosate—Malnutrition—Lamivudine—hepatitis B	0.00233	0.00233	CcSEcCtD
Acamprosate—Diarrhoea—Telbivudine—hepatitis B	0.00231	0.00231	CcSEcCtD
Acamprosate—Flatulence—Lamivudine—hepatitis B	0.0023	0.0023	CcSEcCtD
Acamprosate—Tension—Lamivudine—hepatitis B	0.00229	0.00229	CcSEcCtD
Acamprosate—Dysgeusia—Lamivudine—hepatitis B	0.00228	0.00228	CcSEcCtD
Acamprosate—Nervousness—Lamivudine—hepatitis B	0.00227	0.00227	CcSEcCtD
Acamprosate—Back pain—Lamivudine—hepatitis B	0.00226	0.00226	CcSEcCtD
Acamprosate—Muscle spasms—Lamivudine—hepatitis B	0.00224	0.00224	CcSEcCtD
Acamprosate—Dizziness—Telbivudine—hepatitis B	0.00223	0.00223	CcSEcCtD
Acamprosate—Tremor—Lamivudine—hepatitis B	0.00219	0.00219	CcSEcCtD
Acamprosate—Ill-defined disorder—Lamivudine—hepatitis B	0.00216	0.00216	CcSEcCtD
Acamprosate—Anaemia—Lamivudine—hepatitis B	0.00216	0.00216	CcSEcCtD
Acamprosate—Vomiting—Telbivudine—hepatitis B	0.00215	0.00215	CcSEcCtD
Acamprosate—Angioedema—Lamivudine—hepatitis B	0.00213	0.00213	CcSEcCtD
Acamprosate—Rash—Telbivudine—hepatitis B	0.00213	0.00213	CcSEcCtD
Acamprosate—Dermatitis—Telbivudine—hepatitis B	0.00213	0.00213	CcSEcCtD
Acamprosate—Headache—Telbivudine—hepatitis B	0.00212	0.00212	CcSEcCtD
Acamprosate—Malaise—Lamivudine—hepatitis B	0.0021	0.0021	CcSEcCtD
Acamprosate—Vertigo—Lamivudine—hepatitis B	0.0021	0.0021	CcSEcCtD
Acamprosate—Syncope—Lamivudine—hepatitis B	0.00209	0.00209	CcSEcCtD
Acamprosate—Leukopenia—Lamivudine—hepatitis B	0.00209	0.00209	CcSEcCtD
Acamprosate—Loss of consciousness—Lamivudine—hepatitis B	0.00205	0.00205	CcSEcCtD
Acamprosate—Cough—Lamivudine—hepatitis B	0.00204	0.00204	CcSEcCtD
Acamprosate—Convulsion—Lamivudine—hepatitis B	0.00202	0.00202	CcSEcCtD
Acamprosate—Nausea—Telbivudine—hepatitis B	0.00201	0.00201	CcSEcCtD
Acamprosate—Arthralgia—Lamivudine—hepatitis B	0.00199	0.00199	CcSEcCtD
Acamprosate—Chest pain—Lamivudine—hepatitis B	0.00199	0.00199	CcSEcCtD
Acamprosate—Myalgia—Lamivudine—hepatitis B	0.00199	0.00199	CcSEcCtD
Acamprosate—Anxiety—Lamivudine—hepatitis B	0.00198	0.00198	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00197	0.00197	CcSEcCtD
Acamprosate—Discomfort—Lamivudine—hepatitis B	0.00196	0.00196	CcSEcCtD
Acamprosate—Dry mouth—Lamivudine—hepatitis B	0.00194	0.00194	CcSEcCtD
Acamprosate—Confusional state—Lamivudine—hepatitis B	0.00192	0.00192	CcSEcCtD
Acamprosate—Anaphylactic shock—Lamivudine—hepatitis B	0.0019	0.0019	CcSEcCtD
Acamprosate—Infection—Lamivudine—hepatitis B	0.00189	0.00189	CcSEcCtD
Acamprosate—Shock—Lamivudine—hepatitis B	0.00187	0.00187	CcSEcCtD
Acamprosate—Thrombocytopenia—Lamivudine—hepatitis B	0.00186	0.00186	CcSEcCtD
Acamprosate—Skin disorder—Lamivudine—hepatitis B	0.00185	0.00185	CcSEcCtD
Acamprosate—Hyperhidrosis—Lamivudine—hepatitis B	0.00184	0.00184	CcSEcCtD
Acamprosate—Anorexia—Lamivudine—hepatitis B	0.00182	0.00182	CcSEcCtD
Acamprosate—Hypotension—Lamivudine—hepatitis B	0.00178	0.00178	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00173	0.00173	CcSEcCtD
Acamprosate—Insomnia—Lamivudine—hepatitis B	0.00172	0.00172	CcSEcCtD
Acamprosate—Paraesthesia—Lamivudine—hepatitis B	0.00171	0.00171	CcSEcCtD
Acamprosate—Dyspnoea—Lamivudine—hepatitis B	0.0017	0.0017	CcSEcCtD
Acamprosate—Somnolence—Lamivudine—hepatitis B	0.00169	0.00169	CcSEcCtD
Acamprosate—Dyspepsia—Lamivudine—hepatitis B	0.00168	0.00168	CcSEcCtD
Acamprosate—Decreased appetite—Lamivudine—hepatitis B	0.00166	0.00166	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00164	0.00164	CcSEcCtD
Acamprosate—Constipation—Lamivudine—hepatitis B	0.00163	0.00163	CcSEcCtD
Acamprosate—Pain—Lamivudine—hepatitis B	0.00163	0.00163	CcSEcCtD
Acamprosate—Feeling abnormal—Lamivudine—hepatitis B	0.00157	0.00157	CcSEcCtD
Acamprosate—Gastrointestinal pain—Lamivudine—hepatitis B	0.00156	0.00156	CcSEcCtD
Acamprosate—Urticaria—Lamivudine—hepatitis B	0.00151	0.00151	CcSEcCtD
Acamprosate—Body temperature increased—Lamivudine—hepatitis B	0.00151	0.00151	CcSEcCtD
Acamprosate—Abdominal pain—Lamivudine—hepatitis B	0.00151	0.00151	CcSEcCtD
Acamprosate—Hypersensitivity—Lamivudine—hepatitis B	0.0014	0.0014	CcSEcCtD
Acamprosate—Asthenia—Lamivudine—hepatitis B	0.00137	0.00137	CcSEcCtD
Acamprosate—Pruritus—Lamivudine—hepatitis B	0.00135	0.00135	CcSEcCtD
Acamprosate—Diarrhoea—Lamivudine—hepatitis B	0.0013	0.0013	CcSEcCtD
Acamprosate—Dizziness—Lamivudine—hepatitis B	0.00126	0.00126	CcSEcCtD
Acamprosate—Vomiting—Lamivudine—hepatitis B	0.00121	0.00121	CcSEcCtD
Acamprosate—Rash—Lamivudine—hepatitis B	0.0012	0.0012	CcSEcCtD
Acamprosate—Dermatitis—Lamivudine—hepatitis B	0.0012	0.0012	CcSEcCtD
Acamprosate—Headache—Lamivudine—hepatitis B	0.00119	0.00119	CcSEcCtD
Acamprosate—Nausea—Lamivudine—hepatitis B	0.00113	0.00113	CcSEcCtD
